Search Blog
Categories
November 2013
M T W T F S S
« Oct   Dec »
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

KERX, CTIC, PSTI and OXBT added to NASDAQ Gainer Weekly Watch List at GSR

admin

By Growing Stock Report

New York, NY – (ACCESSWIRE) – 11/04/2013 – Growing Stock Report initiates its NASDAQ Gainers Weekly Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Cell Therapeutics, Inc. (NASDAQ:CTIC), Pluristem Therapeutics, Inc. (NASDAQ:PSTI) and Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) 

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States is currently up (+2.16%) on 779,388 shares traded after Keryx price target raised to $22 from $14 at JMP Securities. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) is currently up (+402.24%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List and Investor Poll. 

To find out what other Investors are saying about Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) 

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=KERX&SubId=AW 

Cell Therapeutics, Inc. (NASDAQ:CTIC) a company that engages in the acquisition, development, and commercialization of treatments for cancer is currently up (+6.75%) on 681,508 shares traded after coverage was initiated on Cell Therapeutics by HC Wainwright. Cell Therapeutics, Inc. (NASDAQ:CTIC) is currently up (+78.35%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List and Investor Poll.

To find out what other Investors are saying about Cell Therapeutics, Inc. (NASDAQ:CTIC)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=CTIC&SubId=AW 

Pluristem Therapeutics, Inc. (NASDAQ:PSTI) a bio-therapeutics company that engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases is currently up (+3.07%) on 44,508 shares traded as Pluristem Therapeutics reports safety of PLX Cells demonstrated in pre-clinical pregnancy model. Pluristem Therapeutics, Inc. (NASDAQ:PSTI) is currently up (+37.65%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List and Investor Poll.

To find out what other Investors are saying about Pluristem Therapeutics, Inc. (NASDAQ:PSTI)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=PSTI&SubId=AW 

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) a development stage company that engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States is currently up (+14.24%) on 2,317,060 shares traded after SmallCapTraders.Com Initiated Coverage of Oxygen Biotherapeutics. Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) is currently up (+1922.22%%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List and Investor Poll.

To find out what other Investors are saying about Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=OXBT&SubId=AW 

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.growingstockreport.com/

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures. 

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com